Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Cleveland Clinic | OTHER |
| The Center for Clinical Research, Winston-Salem, NC | OTHER |
| Anesthesia Pain Care Consultants, Tamarac, FL, USA | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the effectiveness of the Stimwave Spinal Cord Stimulator (SCS) System for treatment of chronic pain
This is a multi-center, prospective study in which subjects will receive a Freedom SCS System and to receive stimulation at a frequency between 5 Hz to 1500 Hz . Enrollment will continue until 49 subjects have been implanted.
Subjects will have chronic back or back and leg pain refractory to standard medical treatment associated with Failed Back Surgery Syndrome (FBSS). Subjects will be followed for a 6-month period after a maximum one-month trial period. At the end of 6 months follow-up, all subjects will assess the outcomes of their appointed therapy and continue with long-term use of the system.
Stimulators will be placed at the following sites to target the painful area:
• Epidural Space midline covering vertebrae levels T8 through T11 (one stimulator placed at the top of T8 and the second stimulator placed at the middle of T9). Paresthesia mapping will be utilised to determine the optimal location for stimulation of the painful area.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Freedom SCS System - 1500 HZ | Experimental | Epidural Space covering vertebrae level T8-T11 determined by paresthesia mapping for painful area. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Freedom SCS System | Device | This Freedom SCS System is based on wireless neuromodulation technology. This technology includes octapolar stimulators with embedded receivers. The energy source is a small, external, rechargeable transmitter, which is worn by the subject. The device is programmed to have a 5-1500 Hz therapy. |
| Measure | Description | Time Frame |
|---|---|---|
| Pain Score | A 50% reduction in VAS scores when compared to baseline. | 6 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage change in VAS Back from baseline | The percentage reduction in VAS back pain | 6 Months |
| Percentage change in VAS Leg from baseline | The percentage reduction in VAS leg pain |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nagy Mekhail | The Cleveland Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nuvo Spine and Sports Institute & Ortho Regenerative Center | Beverly Hills | California | 90212 | United States | ||
Not provided
| ID | Term |
|---|---|
| D001416 | Back Pain |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| Precision Spine Care, Tyler, TX, USA |
| UNKNOWN |
| Nuvo Spine and Sports Institute & Ortho Regenerative Center, Encino, CA, USA | UNKNOWN |
| Compass Research LLC, Orlando, FL, USA | UNKNOWN |
| USC Spine, Keck hospital of USC, Los Angeles, CA, USA | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 6 Months |
| Oswestry Disability Index (ODI) Score | The change from baseline in functionality using the ODI | 6 Months |
| Patient Satisfaction | The change in satisfaction as measured by Patient Global Impression of Change | 6 Months |
| Disability Score | The change in European Quality of Life 5 Dimension | 6 Months |
| Sleep Quality | Frequency of sleep disturbances reported from diary | 6 Months |
| Procedure time | The time measured to implant the device from operative notes | 7 Days post implant |
| Opioid Reduction | The reduction in opioids as reported by patient prescription | 6 Months |
| Adverse Events | The incidence of device related adverse events | 6 Months |
| USC Spine Center, Keck Hospital of USC |
| Los Angeles |
| California |
| 90033 |
| United States |
| Compass Research | Orlando | Florida | 32806 | United States |
| Anesthesia Pain Care Consultants | Tamarac | Florida | 33301 | United States |
| The Center for Clinical Research | Winston-Salem | North Carolina | 27103 | United States |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States |
| Precision Spine Care | Tyler | Texas | 75701 | United States |